Assessment of public hospital drug supply financing through the public-private partnership
pharmacists’ perspectives
DOI:
https://doi.org/10.1590/s2175-97902020000419164Keywords:
Drug Revolving Fund (DRF). Maiduguri. Nigeria. Public Private Partnership (PPP).Abstract
In Nigeria, drug financing by the public has been challenged by financial constraints through public fund due to a limited fund available to the government to meet all its demands. The objectives of this study were to determine the variability of the hospital patient prices of same drugs under the PublicPrivate Partnership (PPP) and in Private Retail Community Pharmacy (PRCP), and to investigate the perceived efficiency and effectiveness of the PPP by comparing it with the Drug Revolving Fund (DRF) model in drug supply financing. This study was conducted in Nigeria utilizing a mixed method. Mann-Whitney U test analysis was used to compare the median drug price of the two facilities. The majority (76.19%) of the drugs were sold at a cheaper rate in the hospital than what was obtained in the PRCP with no significance difference (p > 0.05). Dominant responses from the focused group discussions supported the PPP model. This study shows that the median patient price of the basket of matched pairs of same drugs in the hospital under the PPP and in the PRCP was identical. Overall, the participants were of the opinion that the PPP model was more efficient and effective than DRFin
the financing drug supply.
Downloads
References
Bennett S, Quick JD, Velásquez G. Public-Private Roles in the Pharmaceutical Sector: Implications for equitable access and rational drug use; 1997.
Federal Ministry of Health. Baseline Assessment of the Pharmaceutical Sector; 2002.
Federal Ministry of Health. Revised National Health Policy (NHP), 1st revised ed. Abuja, Nigeria; 2004, p.2-6.
Federal Ministry of Health. National Drug Policy; 2005a, p.14-16.
Federal Ministry of Health. Medicine prices in Nigeria: Prices people pay for medicines; 2006, p.21-22.
Federal Ministry of Health. National Policy on Public Private Partnership for Health in Nigeria; 2005b, p.7-8.
Historical Rates for the USD/NGN currency conversion on 31 January 2017. https://www.poundsterlinglive.com/bestexchange-rates/us-dollar-to-nigerian-naira-exchange-rateon-2017-01-31 (accessed 20 March 2018).
Okoro RN, Shekari BG. Physicians’ drug prescribing patterns at the national health insurance scheme unit of a teaching hospital in the North Eastern Nigeria. Arch Pharma Pract. 2013;4:3-8.
Oseni YO, Afolabi O. Comparative analysis of drug revolving fund (DRF) and public private partnership (PPP) program on drug supply management in University college hospital (UCH), Ibadan, Nigeria. West Afr J Pharm. 2014;25(2):76-87.
Papkalla U, Kupfer G. HIV-related public-private partnership and health system strengthening. UNAIDS, Geneva, Switzerland; 2009, p.1-32.
Schwarz R, Nepal P. Public-private partnership integrated health-care delivery: experience and lessons from Nepal. The LANCET Global Health Blog. 2018. http://globalhealth.thelancet.com/2018/02/20/public-private-partnershipintegrated-health-care-delivery-experience-and-lessonsnepal . (accessed 04 April 2018).
World Health Organization. The World Medicines Situation; 2004.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
